BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7664348)

  • 1. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
    Oku N; Tokudome Y; Tsukada H; Kosugi T; Namba Y; Okada S
    Biopharm Drug Dispos; 1996 Jul; 17(5):435-41. PubMed ID: 8830978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
    Oku N; Namba Y
    Methods Enzymol; 2005; 391():145-62. PubMed ID: 15721379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes.
    Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
    J Drug Target; 1995; 3(1):31-7. PubMed ID: 7655818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake.
    Iga K; Ohkouchi K; Ogawa Y; Toguchi H
    J Drug Target; 1994; 2(3):259-67. PubMed ID: 7812694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes designed to avoid the reticuloendothelial system.
    Papahadjopoulos D; Gabizon A
    Prog Clin Biol Res; 1990; 343():85-93. PubMed ID: 2198586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
    Park YS; Huang L
    J Drug Target; 1993; 1(4):325-30. PubMed ID: 8069575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
    Hatakeyama H; Akita H; Maruyama K; Suhara T; Harashima H
    Int J Pharm; 2004 Aug; 281(1-2):25-33. PubMed ID: 15288340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes.
    Longman SA; Tardi PG; Parr MJ; Choi L; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1177-84. PubMed ID: 8531079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution.
    Plassat V; Martina MS; Barratt G; Ménager C; Lesieur S
    Int J Pharm; 2007 Nov; 344(1-2):118-27. PubMed ID: 17583452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle size-dependent triggering of accelerated blood clearance phenomenon.
    Koide H; Asai T; Hatanaka K; Urakami T; Ishii T; Kenjo E; Nishihara M; Yokoyama M; Ishida T; Kiwada H; Oku N
    Int J Pharm; 2008 Oct; 362(1-2):197-200. PubMed ID: 18586076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
    Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
    Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC
    J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.